Investigation of the Effect of Central Sensitization Symptom Severity on Steroid Injection Results in Shoulder Pain
CompletedNCT06404125
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study was to investigate the effect of the presence and severity of pre-treatment central sensitization on the results of subacromial/ intra-articular shoulder injection in patients with rotator cuff lesion/subacromial impingement. The hypothesis of the study is that the treatment response will decrease in patients with pre-injection central sensitization. There are many studies investigating the frequency of central sensitization in various shoulder pathologies. However, the effect of this condition, which is likely to be associated with chronic pain in these patients, on treatment response is unknown. The effect on the results of shoulder injection, one of the most common procedures in physical therapy practice, will be investigated.
Study details
- Official title
- Investigation of the Effect of Pre-treatment Central Sensitization Severity on Steroid Injection Results in Rotator Cuff-induced Shoulder Pain
- Conditions
- Rotator Cuff Lesion
- Subacromial Impingement Syndrome
- Shoulder Pain
- Chronic Pain
- Interventions
- Diagnostic test: Range of Motion of Shoulde Joint
- Diagnostic test: Hand Grip Test
- Diagnostic test: Numeric Rating Scale
- Diagnostic test: Pain-Pressure Threshold Measurement With an Algometer
- Diagnostic test: Quick Disabilities of the Arm, Shoulder and Hand (Quick-DASH)
- Diagnostic test: Short Form-36
- Diagnostic test: Central Sensitization Scale
- Diagnostic test: Hospital Anxiety and Depression Scale
- Sponsor
- Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- Start date
- 2023-03-01
- Primary completion
- 2024-05-01
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Clinically and radiographically confirmed rotator cuff pathology * Being between the ages of 18-65 * Non-response to medical treatment * Being literate * To agree to participate in the study Exclusion Criteria: * History of shoulder trauma and previous shoulder surgery * Injection in the shoulder area in the last 3 months * History of active cancer, systemic inflammatory disease and infection * Pregnancy * Under 18 and over 65 years of age * Illiteracy * Refusal to participate in the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06404125